Highlights Noxopharm Limited

Equities

NOX

AU000000NOX9

Market Closed - Australian S.E. Other stock markets 08:52:02 2024-07-04 pm EDT			5-day change	1st Jan Change
0.066 ^AUD	-5.71%		0.00%	-7.04%

May. 28	Noxopharm Joins Alliance for mRNA Medicines; Shares Up Nearly 7%	MT
Apr. 04	Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Noxopharm Joins Alliance for mRNA Medicines; Shares Up Nearly 7%	May. 27	MT
Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug	Apr. 03	MT
Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive	Feb. 27	MT
Noxopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 26	CI
Noxopharm Extends Strategic Partnership with Hudson Institute of Medical Research	Feb. 12	MT
Noxopharm Receives AU$6.1 Million R&D tax Rebate; Shares Up 8%	Nov. 15	MT
US FDA Grants Orphan Drug Status to Noxopharm's Pancreatic Cancer Drug; Shares Surge 73%	23-10-04	MT
Noxopharm Validates Efficacy of Cancer Treatment in Animal Study; Shares Rally 13%	23-09-28	MT
Noxopharm Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
NobleOak Life Secures Approval from Financial Services Regulator for Reporting Standards	23-07-03	MT
Noxopharm's NOXO Options to Expire June 18; Shares Down 17%	23-05-08	MT
Noxopharm to Develop Vaccine Enhancer; Shares Rise 3%	23-03-27	MT
Noxopharm Limited Announces Novel mRNA Vaccine Enhancer	23-03-27	CI
Noxopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23	CI
Noxopharm Limited to Present Sofra Study at Lupus 2023 Conference	23-02-21	CI
NobleOak Life to Release Shares from Voluntary Escrow	23-02-08	MT
Noxopharm Limited Reviews Safety Data from the Third Cohort of Patients from the Dose Escalation Part of the DARRT-2 Trial	23-01-16	CI
Noxopharm's Strategic Partner Secures Grant Funding from the Australian Government	22-12-15	MT
Noxopharm Receives Innovation Connections Grant; Shares Fall 5%	22-12-05	MT
Noxopharm Advances Phase 1 Cancer Drug Trial Following Safety Clearance	22-12-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Noxopharm Limited

Equities

NOX

AU000000NOX9

Highlights

Filters